-
Bendamustine has received FDA approval, after priority review, for the treatment of chronic lymphocytic leukemia.
-
A statistically significant improvement in symptoms was observed in the treatment groups, with the honey-child group scoring the best, and the no treatment group doing the most poorly.
-
Mild TBI may be associated with brain microhemorrhages and white matter disruption, even with mild or absent symptoms of a postconcussion syndrome.
-
The proton pump inhibitor rabeprazole is said to provide rapid acid inhibition, but clinical implications of this have been uncertain. This study shows that a single dose of rabeprazole 20 mg administered 5 hours before therapeutic dosing of aspirin significantly decreases gastroduodenal damage.
-
FDA drug approval to change? Urinary incontinence in women; how metabolism of certain drugs can be predicted by genetic analysis; bowel preps may compromise renal function especially in the elderly according to a new study; FDA Actions.
-
-
Chronic wounds represent a significant portion of the complaints seen by physicians, especially in the primary care setting. Visits for wound care account for just over 2% of all visits to office-based physicians in the United States.
-
Why would Emergency Medicine Reports publish an article about "chronic" wounds? As we well know, many patients with chronic conditions come to the emergency department (ED), and those with chronic wounds are no exception. The incidence of chronic skin wounds is likely to increase to due the rise in obesity and diabetes, as well as aging in the general population.
-
-